Mirum Pharmaceuticals, Inc. - MIRM
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 13, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP Ltd. | 9.7% | 5,909,184 | View |
| Aug 06, 2026 | SCHEDULE 13G | FMR LLC | 6.2% | 3,777,851 | View |
| Aug 06, 2026 | SCHEDULE 13G | Abigail P. Johnson | 6.2% | 3,777,851 | View |
| Apr 27, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 5.7% | 3,465,559 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.